Results
|
|
1861.
|
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy. [electronic resource] by
- Bartucci, M
- Svensson, S
- Romania, P
- Dattilo, R
- Patrizii, M
- Signore, M
- Navarra, S
- Lotti, F
- Biffoni, M
- Pilozzi, E
- Duranti, E
- Martinelli, S
- Rinaldo, C
- Zeuner, A
- Maugeri-Saccà, M
- Eramo, A
- De Maria, R
Producer: 20120817
In:
Cell death and differentiation vol. 19
Availability: No items available.
|
|
|
1862.
|
Synergistic effects of topoisomerase I inhibitor, SN38, on Fas-mediated apoptosis. [electronic resource] by
- Cao, Yan
- Jin, Zhe-Xiong
- Tong, Xiao-Peng
- Yue, Sun
- Sakai, Tomoyuki
- Kawanami, Takafumi
- Sawaki, Toshioki
- Miki, Miyuki
- Iwao, Haruka
- Nakajima, Akio
- Masaki, Yasufumi
- Fukushima, Yoshihiko
- Fujita, Yoshimasa
- Nakajima, Hideo
- Okazaki, Toshiro
- Umehara, Hisanori
Producer: 20101210
In:
Anticancer research vol. 30
Availability: No items available.
|
|
|
1863.
|
Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients. [electronic resource] by
- Ceccaldi, Raphael
- Briot, Delphine
- Larghero, Jérôme
- Vasquez, Nadia
- Dubois d'Enghien, Catherine
- Chamousset, Delphine
- Noguera, Maria-Elena
- Waisfisz, Quinten
- Hermine, Olivier
- Pondarre, Corinne
- Leblanc, Thierry
- Gluckman, Eliane
- Joenje, Hans
- Stoppa-Lyonnet, Dominique
- Socié, Gérard
- Soulier, Jean
Producer: 20110203
In:
The Journal of clinical investigation vol. 121
Availability: No items available.
|
|
|
1864.
|
|
|
|
1865.
|
|
|
|
1866.
|
|
|
|
1867.
|
The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1. [electronic resource] by
- Chang, Ling-Chu
- Yu, Yung-Luen
- Liu, Chin-Yu
- Cheng, Yung-Yi
- Chou, Ruey-Hwang
- Hsieh, Min-Tsang
- Lin, Hui-Yi
- Hung, Hsin-Yi
- Huang, Li-Jiau
- Wu, Yang-Chang
- Kuo, Sheng-Chu
Producer: 20150729
In:
Cancer chemotherapy and pharmacology vol. 75
Availability: No items available.
|
|
|
1868.
|
|
|
|
1869.
|
|
|
|
1870.
|
|
|
|
1871.
|
|
|
|
1872.
|
Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51. [electronic resource] by
- Xie, Chengzhi
- Drenberg, Christina
- Edwards, Holly
- Caldwell, J Timothy
- Chen, Wei
- Inaba, Hiroto
- Xu, Xuelian
- Buck, Steven A
- Taub, Jeffrey W
- Baker, Sharyn D
- Ge, Yubin
Producer: 20140818
In:
PloS one vol. 8
Availability: No items available.
|
|
|
1873.
|
|
|
|
1874.
|
Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin. [electronic resource] by
- Nagel, Remco
- Avelar, Ana Teresa
- Aben, Nanne
- Proost, Natalie
- van de Ven, Marieke
- van der Vliet, Jan
- Cozijnsen, Miranda
- de Vries, Hilda
- Wessels, Lodewyk F A
- Berns, Anton
Producer: 20200226
In:
Molecular cancer therapeutics vol. 18
Availability: No items available.
|
|
|
1875.
|
|
|
|
1876.
|
|
|
|
1877.
|
RETRACTED: Selective targeting of checkpoint kinase 1 in tumor cells with a novel potent oncolytic adenovirus. [electronic resource] by
- Gao, Qinglei
- Zhou, Jianfeng
- Huang, Xiaoyuan
- Chen, Gang
- Ye, Fei
- Lu, Yunping
- Li, Kanyan
- Zhuang, Liang
- Huang, Mei
- Xu, Gang
- Wang, Shxuan
- Ma, Ding
Producer: 20060622
In:
Molecular therapy : the journal of the American Society of Gene Therapy vol. 13
Availability: No items available.
|
|
|
1878.
|
ATM-dependent CHK2 activation induced by anticancer agent, irofulven. [electronic resource] by
- Wang, Jian
- Wiltshire, Timothy
- Wang, Yutian
- Mikell, Carmenza
- Burks, Julian
- Cunningham, Cynthia
- Van Laar, Emily S
- Waters, Stephen J
- Reed, Eddie
- Wang, Weixin
Producer: 20041025
In:
The Journal of biological chemistry vol. 279
Availability: No items available.
|
|
|
1879.
|
|
|
|
1880.
|
|